Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Headache after traumatic brain injury

In one third of those affected, they remain forever

    • Neurology
    • RX
    • Studies
  • 3 minute read

Every year, more than 400,000 people in Germany suffer a traumatic brain injury, which can range from a mild concussion to fractures of the skull bone. The most common symptom of traumatic brain injury is headache – and it doesn’t always go away after the acute injury phase. In up to one third of those affected, the headaches become chronic, i.e. they persist for months or even years after the accident. The causes of this are only gradually being understood.

The fact that people who have suffered an impact on the head develop acute headaches is often considered a normal and temporary phenomenon, even by doctors. Often, therefore, targeted treatment only kicks in when the pain does not go away even after a few weeks – by definition, a post-traumatic headache is considered chronic if it persists for more than three months. “However, this significantly underestimates the problem,” says PD Dr. med. Torsten Kraya, head physician at the Clinic for Neurology at Klinikum St. Georg in Leipzig and congress president of the German Pain Congress 2022. Today, it is assumed that the course for the later development of headache symptoms is already set in the acute phase after the traumatic brain injury.

But how do headaches develop in the first place? Visible tissue injuries, such as bleeding or fractures, are often not present in mild traumatic brain injury. Nevertheless, the shock to which the brain is subjected has far-reaching consequences: As recent research shows, the permeability of nerve cell membranes changes abruptly under mechanical stress, resulting in a whole cascade of changes in ionic currents, signaling substances, neuronal activity, cell metabolism, and regional blood flows in the brain. The release of pro-inflammatory substances also appears to play a role in the development of pain. “These acute changes return to normal within a few days or weeks,” Kraya says. It is still not fully understood why pain persists in some people. Presumably, permanent changes in pain perception, the body’s own pain-inhibiting systems, and a dysbalance of the autonomic nervous system, which controls heart rate, respiratory rate, and blood flow, among other things, played a role here. This could also be the cause of many other complaints that can occur after a traumatic brain injury, such as sleep disorders, depression or anxiety disorders. 

A post-traumatic headache of the migraine type is often treated with triptans, while tension headaches are more likely to be treated with aspirin, paracetamol or ibuprofen. Often there are also mixed forms. However, in addition to the choice of medication, the timing of treatment also appears to be critical. “Once the pain takes on a life of its own, it’s very difficult to manage,” Kraya says. Therefore, the tendency today is to take countermeasures with medication as early as possible – especially in patients who have risk factors for chronic pain. These include a pre-existing tendency to headache, younger age, female gender, and migraine-type headache. “Studies also indicate that moderate physical and mental activation is useful as early as 24 or 48 hours after the accident, in part to avoid practicing restraint behaviors and chronicity of pain,” Kraya says. Persons with an increased risk of chronicity should therefore ideally be treated with a multimodal therapy approach, which, in addition to early pain therapy, also includes behavioral therapy elements and, under certain circumstances, targeted activation through physiotherapy.

 

Original publication:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203551/ 

Previous Article
  • Interventional therapy methods

Focus on functional mitral valve regurgitation

  • Cardiology
  • Congress Reports
  • RX
  • Studies
  • Surgery
View Post
Next Article
  • Immunoadsorption (IA)

Advantages over methylprednisolone in MS patients

  • Neurology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 4 min
  • From symptom to diagnosis

Abdominal pain – Sprue

    • Cases
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • Radiology
    • RX
View Post
  • 4 min
  • Case Report

76-year-old patient with pustular skin rash

    • Cases
    • Dermatology and venereology
    • Education
    • Oncology
    • RX
View Post
  • 3 min
  • Sponsored Content: Psoriasis

Dauerhafte Erscheinungsfreiheit auch bei betroffenen speziellen Hautarealen

    • Dermatology and venereology
    • Partner Content
    • Pharmacology and toxicology
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Antithymocyte globulin in children with T1D

Old medicine, new hope

    • Congress Reports
    • Pediatrics
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Ginkgo biloba

Database of preclinical and clinical studies is becoming increasingly larger

    • Education
    • Neurology
    • Pharmacology and toxicology
    • Phytotherapy
    • RX
    • Studies
View Post
  • 6 min
  • Digital biomarkers

Continuous monitoring using digital biomarkers in MS care

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Benefits, limits and safety aspects

Phytotherapy for cardiovascular diseases

    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 6 min
  • Results of the FOREST HCM study

Symptomatic obstructive hypertrophic cardiomyopathy

    • Cardiology
    • Education
    • RX
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Causes and prevention at work
  • 2
    Yellow nail and Swyer-James syndrome
  • 3
    Recommendations for action in practice
  • 4
    From the β-cell to the center: the versatile role of amylin
  • 5
    Communication as the key to therapy adherence

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.